Eight years of qualification
Audited Supplier
In This Store
![4-4-(4-methy-l-piperazinyl)-1-piperidinyl]Benzenamine](https://eimg.pharmasources.com/img_Cphi_en/Product/2018_08/Mimg_1808020431178985.jpg!200)
Fujian South Pharmaceutical Co., Ltd. (FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has become an important cGMP manufacturer for oncology APIs in China. FSP cultivates 7,000 acres of Taxus Wallichiana (Taxus yunnanensis), and it is the largest commercial utilizing in China. FSP is the main supplier for natural Paclitaxel, semi-synthesis Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana) in the world. FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc. FSP is strong in R&D, with a pathbreaking team in Shanghai R&D Center. We hold 6 PCT patents and 33 China patents for processing of taxanes, tabines and tinibs. FSP endeavors to become a well-known oncology pharmaceutical company in the world in next decade.
Year of Establishment: 2001
Total Assets(USD): choose not to disclose
Total Number of Staff: 300 to 349
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights: We hold 9 PCT patents and 39 China patents for processing of taxanes, tabines and tinibs.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight June 2024: Globalization on the Go
